Actively Recruiting

Phase 4
Age: 18Years +
FEMALE
NCT07042581

A Study of Revaree Plus in People With Breast Cancer

Led by Memorial Sloan Kettering Cancer Center · Updated on 2026-02-06

60

Participants Needed

7

Research Sites

208 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The purpose of this study is to find out whether Revaree Plus is effective at improving vaginal health for people who are having symptoms of vaginal dryness during breast cancer treatment.

CONDITIONS

Official Title

A Study of Revaree Plus in People With Breast Cancer

Who Can Participate

Age: 18Years +
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • 18 years of age or older at the time of signing informed consent
  • Diagnosis of stage 0 to 3 hormone-receptor positive breast cancer confirmed at MSKCC
  • Able to complete study questionnaires in English or Spanish
  • Completed primary breast cancer therapy (surgery, chemotherapy, or radiation) or currently on maintenance therapy
  • Currently taking an aromatase inhibitor, tamoxifen, or Selective Estrogen Receptor Modulators (SERM)
  • No clinical evidence of breast cancer disease at the time of study
  • Reporting vaginal symptoms of estrogen deprivation such as vaginal dryness, pain during intercourse, or discomfort during examination
  • A score of 4 or greater on the Vaginal Assessment Scale (VAS)
  • No history of other cancers except non-melanoma skin cancer
  • Willing and able to sign informed consent
Not Eligible

You will not qualify if you...

  • Unable to provide informed consent
  • Vaginal bleeding of unknown cause within 12 months before study entry
  • Currently taking local or systemic hormone replacement therapy (must discontinue for 4 weeks before enrollment)
  • Using external estrogens or nonhormonal moisturizers (must discontinue for 4 weeks before enrollment)
  • Known allergies to any ingredients in the 10mg hyaluronic acid suppository

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 7 locations

1

Memorial Sloan Kettering Basking Ridge (Consent Only)

Basking Ridge, New Jersey, United States, 07920

Actively Recruiting

2

Memorial Sloan Kettering Monmouth (Consent Only)

Middletown, New Jersey, United States, 07748

Actively Recruiting

3

Memorial Sloan Kettering Bergen (Consent Only)

Montvale, New Jersey, United States, 07645

Actively Recruiting

4

Memorial Sloan Kettering Cancer Center Suffolk-Commack (Consent Only)

Commack, New York, United States, 11725

Actively Recruiting

5

Memorial Sloan Kettering Westchester (Consent Only)

Harrison, New York, United States, 10604

Actively Recruiting

6

Memorial Sloan Kettering Cancer Center

New York, New York, United States, 10021

Actively Recruiting

7

Memorial Sloan Kettering Nassau (Consent Only)

Uniondale, New York, United States, 11553

Actively Recruiting

Loading map...

Research Team

S

Shari Goldfarb, MD

CONTACT

J

Jeanne Carter, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

A Study of Revaree Plus in People With Breast Cancer | DecenTrialz